Patent · US Active

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

US12011477B2 · kind B2 · utility

0Cited by

15References

22Claims

0Family size

Assignee

Valneva SE · FR

Inventors

Andrea Fritzer · Wien, AT
Andreas Meinke · Pressbaum, AT
Urban Lundberg · Wien, AT
Mario Nebenführ · Wien, AT
Jürgen Heindl-Wruss · Wien, AT
Robert Schlegl · Siegenfeld, AT
Arnaud Leon · Nantes, FR

Key dates

Filing date	Sep 26, 2022
Grant date	Jun 18, 2024
Priority date	—
Expiry date	Sep 26, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.